During the past decade, Department of Urology Peking University First Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Urology Peking University First Hospital" are "Kidney Neoplasms" (2 trials), "Duodenal Ulcer" (1 trials), "Gastric Ulcer" (1 trials), "Hormone Refractory Prostate Cancer" (1 trials) and "Invasive Bladder Cancer Stage IV" (1 trials). Many other conditions were trialed in "Department of Urology Peking University First Hospital" in a lesser frequency.

Most popular intervention types in "Department of Urology Peking University First Hospital" are "Drug" (6 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bismuth-Containing Quadruple Therapy" (2 trials), "Cyclophosphamide" (2 trials), "IL-2" (2 trials), "Lansoprazole" (2 trials) and "Lansoprazole Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Department of Urology Peking University First Hospital" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Department of Urology Peking University First Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Department of Urology Peking University First Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Urology Peking University First Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".